“Stephen Critchlow, founder and CEO of Evergreen, is a one of a kind personality. In 1989, with a vision to ensure all health decisions were informed at the point of care, he founded Ascribe, a business that grew to serve more than 75% of UK hospitals as well as hospitals overseas. Since then, he’s been an entrepreneur in health and sustainability and has invested over £2m supporting UK-based start-ups and social enterprises. In this eye-opening interview, Stephen reveals his somewhat revolutionary approach towards DNA testing and explains how his app, Evergreen Life, can contribute to science without ever needing a hypothesis.”
Click below to read the full article on DNA Weekly.
